Last 425.00 KRW
Change Today +3.00 / 0.71%
Volume 1.5M
004720 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:21 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

wooridul pharmaceutical ltd (004720) Snapshot

Open
423.00
Previous Close
422.00
Day High
429.00
Day Low
420.00
52 Week High
10/22/13 - 703.00
52 Week Low
01/6/14 - 380.00
Market Cap
33.8B
Average Volume 10 Days
2.0M
EPS TTM
-47.00
Shares Outstanding
79.5M
EX-Date
09/29/94
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for WOORIDUL PHARMACEUTICAL LTD (004720)

Related News

No related news articles were found.

wooridul pharmaceutical ltd (004720) Related Businessweek News

No Related Businessweek News Found

wooridul pharmaceutical ltd (004720) Details

Wooridul Pharmaceutical Limited engages in discovering, developing, and providing pharmaceuticals and other healthcare products in South Korea. The company offers ETC drugs, including antiepileptic, anti-inflammatory, antiphlogistic, central nervous system, urinary, antihistamine, antivirus, bone, liver, and calcium agents; respiratory, gastrointestinal, and circulatory system products; and diabetes, antibiotic, dermatological, muscle relaxant, antispasmodic, injection, and syrup products. It also provides OTC and obesity drugs, as well as health foods. The company was formerly known as Wooridul Life Science Ltd. and changed its name to Wooridul Pharmaceutical Limited in December 2009. Wooridul Pharmaceutical Limited was founded in 1957 and is headquartered in Daegu, South Korea.

Founded in 1957

wooridul pharmaceutical ltd (004720) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

wooridul pharmaceutical ltd (004720) Key Developments

Wooridul Pharmaceutical Limited, Annual General Meeting, Mar 31, 2014

Wooridul Pharmaceutical Limited, Annual General Meeting, Mar 31, 2014., at 08:00 Korea Standard Time. Location: hyangnameup Pharmaceutical Corporation, Hwaseong-si. Agenda: To consider consolidated financial statements; to consider the election of directors; to consider directors' remuneration limit; and to consider audit fee limit.

Wooridul Pharmaceutical Limited, Annual General Meeting, Mar 27, 2013

Wooridul Pharmaceutical Limited, Annual General Meeting, Mar 27, 2013., at 09:00 Korea Standard Time. Location: Hwaseong-si, hyangnameup sangsinri 902-5. Agenda: To approve financial statements (including disposition of accumulated deficit) and consolidated financial statements for the year ended December 31, 2012; to consider election of director of the board of directors; to approve directors' remuneration limit; and to approve audit fees limit.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
004720:KS 425.00 KRW +3.00

004720 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 004720.
View Industry Companies
 

Industry Analysis

004720

Industry Average

Valuation 004720 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 1.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WOORIDUL PHARMACEUTICAL LTD, please visit www.wooridulpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.